Entry |
|
Name |
KSHV vIRF2 to IFN signaling pathway
|
Definition |
vIRF2 -| (STAT1+STAT2+IRF9) |
Expanded |
K21654 -| (6772+6773+10379) |
Class |
nt06517 TLR signaling
nt06222 IFN signaling (cancer)
nt06164 Kaposi sarcoma-associated herpesvirus (KSHV)
|
Type |
Pathogen
|
Pathway |
hsa05167 | Kaposi sarcoma-associated herpesvirus infection |
|
Disease |
|
Gene |
6772 | STAT1; signal transducer and activator of transcription 1 |
6773 | STAT2; signal transducer and activator of transcription 2 |
10379 | IRF9; interferon regulatory factor 9 |
|
Perturbant |
K21654 (vIRF2) | vIRF2; KSHV interferon regulatory factor-like protein 2 |
|
Reference |
|
Authors |
Schulz TF, Cesarman E |
Title |
Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis. |
Journal |
|
Reference |
|
Authors |
Mutocheluh M, Hindle L, Areste C, Chanas SA, Butler LM, Lowry K, Shah K, Evans DJ, Blackbourn DJ |
Title |
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor-2 inhibits type 1 interferon signalling by targeting interferon-stimulated gene factor-3. |
Journal |
|
Reference |
|
Authors |
Rezaee SA, Cunningham C, Davison AJ, Blackbourn DJ |
Title |
Kaposi's sarcoma-associated herpesvirus immune modulation: an overview. |
Journal |
|
Reference |
|
Authors |
Liang C, Lee JS, Jung JU |
Title |
Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis. |
Journal |
|
LinkDB |
|